An Open-Label, Multicenter, Phase 1b Study of Daratumumab in Combination with Backbone Regimens in Patients with Multiple Myeloma

被引：5

作者：

Moreau, Philippe ^{[1
]}

Mateos, Maria-Victoria ^{[2
]}

Blade, Joan ^{[3
]}

Benboubker, Lotfi ^{[4
]}

de la Rubia, Javier ^{[5
,6
]}

Facon, Thierry ^{[7
]}

Comenzo, Raymond L. ^{[8
]}

Fay, Joseph W. ^{[9
]}

Qin, Xiang ^{[10
]}

Masterson, Tara ^{[10
]}

Schecter, Jordan ^{[11
]}

Ahmadi, Tahamtan ^{[10
]}

San Miguel, Jesus ^{[12
]}

机构：

[1] Univ Hosp Nantes, Nantes, France

[2] Univ Hosp Salamanca IBSAL, Salamanca, Spain

[3] Hosp Clin Barcelona, IDIBAPS, Barcelona, Spain

[4] Hop Bretonneau, CHU Tours, Tours, France

[5] Hosp La Fe, E-46009 Valencia, Spain

[6] Univ Catolica San Vicente Martir, Valencia, Spain

[7] CHRU Lille, F-59037 Lille, France

[8] Tufts Med Ctr, Boston, MA USA

[9] Baylor Inst Immunol Res, Dallas, TX USA

[10] Janssen Pharmaceut Res & Dev, Spring House, PA USA

[11] Janssen Pharmaceut Res & Dev, Raritan, NJ USA

[12] Univ Navarra Clin, Pamplona, Spain

来源：

关键词：

D O I：

10.1182/blood.V124.21.3359.3359

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3